Primary Site >> Esophagus Cancer

Gene >> BID

Journal: Hokkaido Igaku Zasshi. 1993 Jul;68(4):537-56.
Title: [Study on clinical application of multiple fractions per day radiation therapy with concomitant boost technique for esophageal cancer].
Author: Kikuchi, Y
PMID: 8340051
Journal: Am J Surg. 1995 May;169(5):557-9.
Title: Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
Author: Girvin, G W|Matsumoto, G H|Bates, D M|Garcia, J M|Clyde, J C|Lin, P H
PMID: 7747839
Journal: Med Oncol. 1995 Jun;12(2):115-20.
Title: Phase II trial of chemotherapy, external and intraluminal radiation plus surgery for oesophageal cancer.
Author: Beitler, J J|Wadler, S|Haynes, H|Fell, S|Rozenblit, A|Wolf, E|Levine, B A
PMID: 8535661
Journal: Mol Biol Rep. 2014 May;41(5):3009-20.
Title: Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells.
Author: Wang, Qiao|Du, Haoxin|Geng, Guojun|Zhou, Huan|Xu, Minying|Cao, Hanwei|Zhang, Bing|Song, Gang|Hu, Tianhui
PMID: 24510386
Journal: Invest New Drugs. 2015 Jun;33(3):641-51.
Title: Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
Author: Nakamichi, Shinji|Nokihara, Hiroshi|Yamamoto, Noboru|Yamada, Yasuhide|Fujiwara, Yutaka|Tamura, Yosuke|Wakui, Hiroshi|Honda, Kazunori|Mizugaki, Hidenori|Kitazono, Satoru|Tanabe, Yuko|Asahina, Hajime|Yamazaki, Naoya|Suzuki, Shigenobu|Matsuoka, Mieko|Ogita,
PMID: 25809858
Journal: Eur J Med Chem. 2018 Mar 25;148:359-371.
Title: Potent hydrazone derivatives targeting esophageal cancer cells.
Author: Li, Ling-Yu|Peng, Jia-Di|Zhou, Wenjuan|Qiao, Hui|Deng, Xin|Li, Zhou-Hua|Li, Ji-Deng|Fu, Yun-Dong|Li, Song|Sun, Kai|Liu, Hong-Min|Zhao, Wen
PMID: 29475156